Wahlstrom Mats
SEC CIK 1459154 · EDGAR
BoughtSold
Most active insiders at CHRS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ryan Michael Lee | Dir | — | — |
| 2 | McMichael Bryan J | CFO | — | — |
| 3 | O'Donnell-Tormey Jill | Dir | — | — |
| 4 | Newton Charles W. | Dir | — | — |
| 5 | Newcomer Lee Nisley | Dir | — | — |
| 6 | Satvat Ali J. | Dir | — | — |
| 7 | Karachun Rita A | Dir | — | — |
| 8 | Wahlstrom Mats | Dir | — | — |
| 9 | Lanfear Dennis M | Pres, CEO, Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-09 18:40 | 2026-06-05 | CHRS | Coherus Oncology, Inc. | Wahlstrom Mats | Dir | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
| 2026-05-18 16:42 | 2026-05-15 | TLSI | TriSalus Life Sciences, Inc. | Wahlstrom Mats | Dir | P - Purchase | $2.53 | +60.0K | 147.6K | +69% | +$151.8K | |
| DM | 2026-05-15 16:39 | 2026-05-14 | TLSI | TriSalus Life Sciences, Inc. | Wahlstrom Mats | Dir | A - Grant | $0.00 | +71.8K | 87.6K | +457% | $0 |
| I | 2025-05-28 | 2025-05-23 | CHRS | Coherus Oncology, Inc. | Wahlstrom Mats | Dir | S - Sale | $0.74 | -100.0K | 0 | -100% | -$74.0K |
| 2024-12-19 | 2024-12-17 | TLSI | TriSalus Life Sciences, Inc. | Wahlstrom Mats | Dir, 10% | A - Grant | $3.97 | +25.2K | 40.9K | +160% | +$100.0K | |
| 2024-11-25 | 2024-11-22 | TLSI | TriSalus Life Sciences, Inc. | Wahlstrom Mats | Dir, 10% | P - Purchase | $4.55 | +5,000 | 15.7K | +47% | +$22.8K | |
| M | 2024-11-22 | 2024-11-20+ | TLSI | TriSalus Life Sciences, Inc. | Wahlstrom Mats | Dir, 10% | P - Purchase | $4.39 | +10.7K | 2,040 | New | +$47.1K |
| 2024-02-15 | 2024-02-09 | CHRS | Coherus Oncology, Inc. | Wahlstrom Mats | Dir | G - Gift | $0.00 | -100.0K | 0 | -100% | $0 | |
| I | 2024-02-15 | 2024-02-09 | CHRS | Coherus Oncology, Inc. | Wahlstrom Mats | Dir | G - Gift | $0.00 | +100.0K | 100.0K | New | $0 |
| DM | 2024-02-05 | 2024-02-01 | CHRS | Coherus Oncology, Inc. | Wahlstrom Mats | Dir | M - OptEx | $1.67 | +60.0K | 100.0K | +150% | +$100.2K |
| DM | 2022-03-01 | 2022-02-25+ | CHRS | Coherus Oncology, Inc. | Wahlstrom Mats | Dir | A - Grant | $4.47 | +40.0K | 40.0K | New | +$178.9K |
Purchase Sale Sale after option exercise All abbreviations